Family Medicine · Purvis, MS
NPI
1336151976
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
101 Weems St
Purvis, MS, 39475
Phone (601) 794-2224
Groups this clinician bills Medicare through
Medicare paid, 2024
$205K
12,598 services
Medicare patients, 2024
536
Average age 74
Drug cost, 2024
$1.1M
22,928 prescriptions
Company payments, 2025
$679
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen L Harless was code J0897 (injection, denosumab, 1 mg), 1,980 times for 23 patients. In total Stephen L Harless billed 12,598 services in 55 codes, and Medicare paid $205K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,980 | 23 | $20.19 | $40K |
| 99213 Office E&M - Established | Office | 834 | 395 | $48.94 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 831 | 352 | $9.90 | $8,228 |
| 99214 Office E&M - Established | Office | 473 | 282 | $73.84 | $35K |
| 36415 Venipuncture Blood Collection | Office | 366 | 259 | $8.65 | $3,166 |
| 80305 Drug Tests | Office | 277 | 108 | $12.22 | $3,386 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 270 | 104 | $4.19 | $1,130 |
| 96372 Injection Administration | Office | 250 | 145 | $7.98 | $1,995 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 238 | 238 | $117.38 | $28K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 194 | 28 | $40.93 | $7,940 |
| G0008 Administration of influenza virus vaccine | Office | 161 | 155 | $29.46 | $4,743 |
| 90662 Vaccine Product | Office | 153 | 147 | $81.11 | $12K |
| 81003 Clinical Chemistry | Office | 93 | 66 | $2.20 | $205 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 74 | 13 | $0.56 | $41.76 |
| 85610 Clinical Chemistry | Office | 43 | 11 | $4.05 | $174 |
By year: 2022 $266K for 19,459 services; 2023 $249K for 18,687 services; 2024 $205K for 12,598 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 366 | 259 | $8.65 | $3,166 |
| 80305 Drug Tests | 277 | 108 | $12.22 | $3,386 |
| 81003 Clinical Chemistry | 93 | 66 | $2.20 | $205 |
| 85610 Clinical Chemistry | 43 | 11 | $4.05 | $174 |
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 35 | 35 | $17.69 | $619 |
| 85025 Blood Count | 19 | 17 | $7.61 | $145 |
| 82274 Immunoassay | 16 | 16 | $15.60 | $250 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen L Harless prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,055 prescriptions and refills. In total Stephen L Harless wrote 22,928 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,055 | 2,189 | 249 | $8,766 |
| Rosuvastatin Calcium Generic | 1,031 | 2,240 | 251 | $8,047 |
| Amlodipine Besylate Generic | 767 | 1,777 | 185 | $3,187 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 752 | 752 | 100 | $13K |
| Atorvastatin Calcium Generic | 720 | 1,728 | 183 | $5,446 |
| Gabapentin Generic | 644 | 960 | 128 | $9,347 |
| Furosemide Generic | 617 | 1,166 | 161 | $2,093 |
| Diclofenac Sodium Generic | 579 | 949 | 164 | $10K |
| Tizanidine Hcl Generic | 479 | 653 | 118 | $2,294 |
| Cefuroxime Cefuroxime Axetil | 422 | 422 | 292 | $7,322 |
| Meloxicam Generic | 420 | 839 | 98 | $1,513 |
| Metformin Hcl Generic | 410 | 978 | 105 | $2,803 |
| Levothyroxine Sodium Generic | 387 | 862 | 83 | $3,345 |
| Glimepiride Generic | 379 | 900 | 92 | $3,057 |
| Trazodone Hcl Generic | 374 | 630 | 84 | $1,856 |
Brand drugs: 1,732 claims; generic drugs: 21,089 claims; opioid claims: 1,006.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen L Harless $679 ($679 in general payments such as food, travel and fees) from 16 companies. The largest payer was Novo Nordisk Inc with $155.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 9 | $155 |
| Pfizer Inc. PFE | 17 | $143 |
| Lilly USA, LLC LLY | 3 | $58.4 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $42.28 |
| Amgen Inc. AMGN | 2 | $42.17 |
| Lundbeck LLC | 2 | $38.81 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $37.28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $33.8 |
| Exact Sciences Corporation EXAS | 1 | $19.06 |
| Abbott Laboratories ABT | 1 | $18.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.